Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis.
Axtell RC, de Jong BA, Boniface K, van der Voort LF, Bhat R, De Sarno P, Naves R, Han M, Zhong F, Castellanos JG, Mair R, Christakos A, Kolkowitz I, Katz L, Killestein J, Polman CH, de Waal Malefyt R, Steinman L, Raman C. Axtell RC, et al. Among authors: de jong ba, de sarno p, de waal malefyt r. Nat Med. 2010 Apr;16(4):406-12. doi: 10.1038/nm.2110. Epub 2010 Mar 28. Nat Med. 2010. PMID: 20348925 Free PMC article.
Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein.
Herges K, de Jong BA, Kolkowitz I, Dunn C, Mandelbaum G, Ko RM, Maini A, Han MH, Killestein J, Polman C, Goodyear AL, Dunn J, Steinman L, Axtell RC. Herges K, et al. Among authors: de jong ba. Mult Scler. 2012 Apr;18(4):398-408. doi: 10.1177/1352458512440060. Epub 2012 Feb 16. Mult Scler. 2012. PMID: 22343184 Free PMC article.
Regulator of oligodendrocyte maturation, miR-219, a potential biomarker for MS.
Bruinsma IB, van Dijk M, Bridel C, van de Lisdonk T, Haverkort SQ, Runia TF, Steinman L, Hintzen RQ, Killestein J, Verbeek MM, Teunissen CE, de Jong BA. Bruinsma IB, et al. Among authors: de jong ba. J Neuroinflammation. 2017 Dec 4;14(1):235. doi: 10.1186/s12974-017-1006-3. J Neuroinflammation. 2017. PMID: 29202778 Free PMC article.
Mild progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab.
Toorop AA, van Lierop ZYG, Strijbis EEM, Teunissen CE, Petzold A, Wattjes MP, Barkhof F, de Jong BA, van Kempen ZLE, Killestein J. Toorop AA, et al. Among authors: de jong ba. Neurol Neuroimmunol Neuroinflamm. 2020 Oct 13;8(1):e904. doi: 10.1212/NXI.0000000000000904. Print 2021 Jan. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 33051344 Free PMC article.
Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic.
van Lierop ZY, Toorop AA, van Ballegoij WJ, Olde Dubbelink TB, Strijbis EM, de Jong BA, van Oosten BW, Moraal B, Teunissen CE, Uitdehaag BM, Killestein J, Kempen ZLV. van Lierop ZY, et al. Among authors: de jong ba. Mult Scler. 2022 Jun;28(7):1121-1125. doi: 10.1177/13524585211028833. Epub 2021 Jul 9. Mult Scler. 2022. PMID: 34240631 Free PMC article.
122 results